ArticleJIMD reports2023

Screening data from 19 patients with late-onset Pompe disease for a phase I clinical trial of AAV8 vector-mediated gene therapy.

William B Hannah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.